II. Epidemiology
- First recognized Outbreak: Lassa, Nigeria (1969)
- Endemic to West Africa
- Nigeria
- Liberia
- Sierra Leone
- Senegal
- Gambia
- Guinea
- Ghana
- Burkina Faso (Upper Volta)
- Mali
- Ivory Coast
III. Pathophysiology
- Lassa Virus is an Arenavirus that is classified as a Viral Hemorrhagic Fever
-
Arenaviruses (Arenaviridae) are a family of viruses causing Viral Hemorrhagic Fever
- Arenaviridae primarily cause Viral Hemorrhagic Fever (except LCMV)
- Arenaviridae are Enveloped, helical, segmented, single stranded RNA Viruses
- Arenaviridae infect rodents as main reservoir, and transmit to humans via contact with urine
-
Arenaviruses are Anti-Message Sense RNA Viruses (Negative Stranded, -ssRNA)
- Anti-Message sense RNA (-ssRNA) need to first be transcribed into +ssRNA
- RNA dependent RNA Polymerase (RNA replicase, RdRp)
- RdRp is an enzyme carried by the -ssRNA virus within its capsid
- RdRp transcribes -ssRNA into +ssRNA within the host cell
- Translation follows +ssRNA transcription from -ssRNA (by RdRp)
- As with mRNA, +ssRNA translated by host ribosomes into Protein
- Transmission
- Incubation: 1-24 days
- Multimammate Rats (Mastomys natalensis) are reservoir
- Contamination of food with rodent urine
- Person to person blood or body fluid contact
- Urine
- Feces
- Vomit
- Saliva
IV. Symptoms
- Early, Insidious symptoms
- Second week symptoms
- Lower Abdominal Pain
- Intractable Vomiting
- Other symptoms
- Tinnitus
- Epistaxis
- Bleeding Gums
- Maculopapular rash
- Cough
- Dizziness
V. Signs
- Early
- Fever
- Flushing of face and V-neck area
- Pharyngitis (progressive over first week)
- Raised patch of whitish exudate on Tonsillar Pillar
- Pseudomembranes may develop
- Oral Ulcerations (50%)
- Generalized non-tender Lymphadenopathy (50%)
- Later
- Facial and neck swelling
- Conjunctivitis
- Severe, Acute Phase
- Systolic Blood Pressure below 90 (60-80%)
- Pulse Pressure less than 20
- Relative Bradycardia
VI. Labs
-
Complete Blood Count
- Hematocrit normal
-
White Blood Cell Count low (Leukopenia)
- Relative Neutrophilia
- Erythrocyte Sedimentation Rate normal
-
Liver Function Tests
- Aspartate Aminotransferase (AST, SGOT) elevated
- Creatinine phosphokinase (CPK) elevated
- Lactate Dehydrogenase (LDH) elevated
-
Urinalysis
- Severe Proteinuria
- Lassa Virus Antibody titer
- Fourfold rise between acute and convalescent phase
VII. Radiology
-
Chest XRay
- Basilar pneumonitis
- Pleural Effusions
VIII. Diagnostics
-
Electrocardiogram
- May show diffuse Myocardial Disease
IX. Complications
- Oculogyric Crisis (rapid involuntary eye movement)
- Deafness
- Alopecia
X. Course
- Illness lasts 7 to 31 days (average 12-15 days)
XI. Prognosis
- Mortality: 8 to 52%
- Signs suggestive of poor prognosis or death
- Shock
- Altered Level of Consciousness
- Auscultated Rales
- Pleural Effusion
- Grand Mal Seizures
XIII. Management
- Supportive care
-
Ribavirin (Virazole)
- See Viral Hemorrhagic Fever for protocol
- Appears highly effective
- Infusion of immune plasma from convalescent patients
- Isolation Procedures
- Respiratory isolation
- Blood and Body fluid precautions
XIV. References
- Seeyave (2015) Crit Dec Emerg Med 29(5): 13-21
- Wilson (1991) Harrison's PIM, Mcgraw Hill, pp. 740-1